Panacea Biotec informs about press release

28 Mar 2016 Evaluate

Panacea Biotec has informed about a Press Release dated March 28, 2016 titled ‘Panacea Biotec Launches - CABAPAN, A Cost Effective product for the treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC)’.

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

319.50 -8.55 (-2.61%)
27-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.65
Dr. Reddys Lab 1281.95
Cipla 1242.65
Zydus Lifesciences 896.60
Lupin 2334.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×